ProCE Banner Activity

A European Perspective on the Key Studies in Multiple Myeloma Presented at ASH 2019

Clinical Thought
In this commentary, Jesús F. San-Miguel, MD, PhD, provides his perspective on key studies from ASH 2019.

Released: January 28, 2020

Expiration: January 26, 2021

Share

Faculty

Jesus San-Miguel

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Supporters

Supported by educational grants from

AbbVie

AstraZeneca

Gilead

Jazz Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

Jesús F. San-Miguel, MD, PhD, has disclosed that he has received consulting fees from Amgen, Bristol-Myers Squibb, Celgene, Janssen, MSD, Novartis, Roche, Sanofi, and Takeda.